Menu
Recruiting NCT05571774

Construction of a Database for TTP

— Observational TTP - Thrombotic Thrombocytopenic Purpura

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: collection data.
Who it may be relevant to
Registry conditions: TTP - Thrombotic Thrombocytopenic Purpura. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Construction of a Database for Thrombotic Thrombocytopenic Purpura

Overview

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Oct 20, 2022, to Oct 20, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical related data of thrombotic thrombocytopenic purpura.

Interventions

  • Other collection data
    collection data

Primary outcome measures

  • Number of participants with stroke [Time frame: 5 years from the time of entering the database.]

Eligibility criteria

Inclusion criteria

\- Subjects diagnosed with severe ADAMTS13 deficiency, defined as ADAMTS13 activity <10%, documented in the patient's medical history or at screening.

Exclusion criteria

\- The investigator considers the subject unable or unwilling to cooperate with the study procedures.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

China · 1 center
  • the first affiliated hospital of Soochow university — Suzhou

Identifiers

NCT: NCT05571774 · SOOCHOW-HY-2022-12

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗